‘In February, the WHO brought together hundreds of scientists and researchers to identify research priorities (…). Some therapies, such as the use of dexamethasone, demonstrated their efficacy in seriously ill and critical COVID-19 patients; and now there are around 180 ongoing vaccines, including 35 in clinical trials,’ he noted.
In this regard, the spokesperson for the international body in Russia, Melita Vujnovic, told the Sputnik news agency, that the WHO welcomes as hopeful the fact that over 30 candidate vaccines are going through different phases of clinical trials.
She further stressed that the organization continues to cooperate with Russian scientists and authorities and is eagerly awaiting the possibility of studying the details of the Sputnik V vaccine tests.
Recently, a study issued in The Lancet certified that Sputnik V is safe and produces an immune response.
Other valuable candidates are China’s Sinovac, which began phase III several weeks ago after the company was authorized in Brazil to carry out experimental tests on volunteers.
In Latin America, the Cuban vaccine candidate Soberana 01 started clinical trials on August 24 and after injecting 40 volunteers between 18 and 80 years old, health authorities do not report adverse reactions.